Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Procaps Group ( (PROCF) ) has provided an update.
On March 24, 2025, Procaps Group’s Board approved a private offering of ordinary shares to raise up to $90 million, excluding proceeds from previously issued secured convertible notes. By April 3, 2025, the company entered into subscription agreements with various investors to purchase shares at $0.06313 each. On April 9, 2025, Procaps finalized the equity raise and converted secured convertible notes, issuing over 2 billion shares and warrants. This move aims to strengthen the company’s financial position and support its operational needs.
More about Procaps Group
Procaps Group, S.A. operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is based in Luxembourg and engages in activities related to equity raises and convertible note agreements.
YTD Price Performance: -36.91%
Average Trading Volume: 24,430
Technical Sentiment Signal: Strong Buy
Current Market Cap: $165.9M
For a thorough assessment of PROCF stock, go to TipRanks’ Stock Analysis page.